SCHEMBL17805201

SCHEMBL17805201

c1cncc(-c2c3ccccc3c(-c3ccc4nn(-c5ccc(-c6c7ccccc7c(-c7cnc8ccccc8c7)c7ccccc67)cc5)nc4c3)c3ccccc23)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.52
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
MAPT P10636 3/20 0.40
ALDH1A1 P00352 2/20 0.40
PDGFRB P09619 3/20 0.40
PDGFRA P16234 3/20 0.40
PIK3CD O00329 3/20 0.39
PIK3CA P42336 3/20 0.39
CYP11B1 P15538 2/20 0.38
MTOR P42345 2/20 0.38
CYP17A1 P05093 1/20 0.38
CYP19A1 P11511 1/20 0.38
CYP11B2 P19099 1/20 0.38
PIK3CB P42338 1/20 0.38
PIK3CG P48736 1/20 0.38
MAPK1 P28482 1/20 0.36
GRM1 Q13255 1/20 0.36
EGFR P00533 1/20 0.36
POLB P06746 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17805250 1.00 CYP2A6 (0.52) CYP2A6NPC1RAB9AMAPTALDH1A1
SCHEMBL30911058 0.96 CYP2A6 (0.55) CYP2A6NPC1RAB9AMAPTALDH1A1
SCHEMBL15949874 0.96 CYP2A6 (0.55) CYP2A6NPC1RAB9AMAPTALDH1A1
SCHEMBL17805254 0.91 NPC1 (0.46) CYP2A6NPC1RAB9AMAPTALDH1A1
SCHEMBL17805262 0.89 CYP11B1 (0.50) CYP2A6NPC1RAB9AMAPTALDH1A1
SCHEMBL17812852 0.89 NPC1 (0.43) CYP2A6NPC1RAB9AMAPTALDH1A1
SCHEMBL17805219 0.88 PIK3CA (0.46) CYP2A6NPC1RAB9AMAPTALDH1A1
SCHEMBL17812842 0.88 PIK3CA (0.46) CYP2A6NPC1RAB9AMAPTALDH1A1
SCHEMBL17812847 0.88 MAPT (0.45) NPC1RAB9AMAPTALDH1A1CYP11B1
SCHEMBL10018423 0.86 CYP11B2 (0.56) CYP2A6NPC1RAB9AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10593884-B2 Organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2020-03-17 US disclosed
US-20180006235-A1 ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2018-01-04 US disclosed
US-9842999-B2 Benzotriazole derivative and an organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2017-12-12 US disclosed
US-9842999-B2 Benzotriazole derivative and an organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2017-12-12 US disclosed
US-20170346009-A1 ORGANIC ELECTROLUMINESCENT DEVICE SFC CO., LTD. (KR) 2017-11-30 US disclosed
US-20170346009-A1 ORGANIC ELECTROLUMINESCENT DEVICE SFC CO., LTD. (KR) 2017-11-30 US disclosed
WO-2016111254-A1 ORGANIC ELECTROLUMINESCENT ELEMENT 保土谷化学工業株式会社 2016-07-14 WO disclosed
US-20160164001-A1 A BENZOTRIAZOLE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2016-06-09 US disclosed
US-20160164001-A1 A BENZOTRIAZOLE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2016-06-09 US disclosed
EP-3029034-A1 BENZOTRIAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT Hodogaya Chemical Co., Ltd. (JP) 2016-06-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10593884-B2 Organic electroluminescent device AHR, SLC18A1, KCNH1 CYP2A6 1064/4885NPC1 1334/4885RAB9A 2537/4885
US-20180006235-A1 ORGANIC ELECTROLUMINESCENT DEVICE AHR, SLC18A1, KCNH1 CYP2A6 1064/4885NPC1 1334/4885RAB9A 2537/4885
US-20160164001-A1 A BENZOTRIAZOLE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT DEVICE AHR, ARNT, NAT1 CYP2A6 2471/4885NPC1 4372/4885RAB9A 4713/4885
US-20170346009-A1 ORGANIC ELECTROLUMINESCENT DEVICE AHR, SLC18A1, ARNT CYP2A6 802/4885NPC1 1622/4885RAB9A 2172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.